Your browser doesn't support javascript.
loading
Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort.
Cuzick, J; Berney, D M; Fisher, G; Mesher, D; Møller, H; Reid, J E; Perry, M; Park, J; Younus, A; Gutin, A; Foster, C S; Scardino, P; Lanchbury, J S; Stone, S.
Affiliation
  • Cuzick J; Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary, University of London, Charterhouse Square, London EC1 M 6BQ, UK. j.cuzick@qmul.ac.uk
Br J Cancer ; 106(6): 1095-9, 2012 Mar 13.
Article in En | MEDLINE | ID: mdl-22361632

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Adenocarcinoma / Cell Cycle Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Humans / Male Language: En Journal: Br J Cancer Year: 2012 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Adenocarcinoma / Cell Cycle Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Humans / Male Language: En Journal: Br J Cancer Year: 2012 Document type: Article